Background: Recent studies of melanin biosynthesis have uncovered an unusual enzymatic activity which converts the non-naturally occurring D-isomer of 2-carboxy-2, 3-dihydroindole-5,6-quinone (dopachrome) into 5,6-dihydroxyindole-2-carboxylic acid (DHICA). The aim of the present investigation was to isolate and characterize the enzyme catalyzing this tautomerization reaction. Materials and Methods: After we performed a tissue survey of D-dopachrome tautomerase activity, 10 bovine lenses were homogenized and used as a source of enzyme. A soluble fraction was obtained by high-speed centrifugation and subjected to successive FPLC chromatography on Phenyl-sepharose, Mono S cation-exchange, and Superdex gel-filtration. The isolated enzyme was electrophoresed, blotted onto PVDF membrane, and the N terminus analyzed by gas phase micro-sequencing. Results: The protein catalyzing the conversion of Ddopachrome to DHICA was purified to homogeneity in 14% yield and showed a molecular weight of 12 kD when analyzed by SDS-PAGE. The first 27 amino acid residues of this protein were sequenced and found to be
INTRODUCTION
The mediator originally described as macrophage migration inhibitory factor (MIF) has been redefined recently to be an anterior pituitary hormone, a macrophage cytokine, and a critical component of the host response to septic shock (1) (2) (3) (4) . MIF exists pre-formed in various cell types and in the last few years has been fortuitously identified in several other organ systems and physiological contexts (5-7). The present report describes an enzymatic activity for MIF that was uncovered during an investigation of the biochemical pathways of melanogenesis.
The late stages of melanin biosynthesis involve the enzymatic conversion of 2-carboxy-2,3-dihydroindole-5,6-quinone (dopachrome) into 5,6-di- hydroxyindole-2-carboxylic acid (DHICA) (8, 9) . Two melanocytic enzymes catalyze the tautomerization of dopachrome to DHICA and are specific for the naturally occurring L-dopachrome stereoisomer (10) (11) (12) . In a recent study of cultured melanoma cells, however, the conversion of D-dopachrome to 5,6-dihydroxyindole (DHI) was observed when the D-isomer of dopachrome was added as a control substrate (13 The sample which eluted from the PD-10 column was applied to a Mono S HR5/5 FPLC column equilibrated with 50 mM NaAc buffer, pH 5.5. The column was washed with 5 ml of the equilibration buffer and then eluted with a linear gradient of 0.0-1.0 M NaCl in the same buffer. The flow rate was 1 ml/min and elution continued for 25 min. The fractions catalyzing DHICA formation were concentrated with a Centricon-10 concentrator and applied to a PD-10 Sephadex column where the buffer was changed to 20 mM Tris (pH 7.1) and 50 mM NaCl.
The sample obtained after The purity and homogeneity of the bovine lens enzyme were established by SDS-PAGE (Fig. 3) . Under reducing conditions, a single polypeptide of molecular weight 12 kD was observed. A 27-amino acid N-terminal sequence was obtained and identified this protein to be the bovine homolog of MIF (Fig. 4) (6) .
A procedure for the preparation of pure, bioactive recombinant MIF was recently described (15) . The ability of native MIF to catalyze the tautomerization of D-dopachrome to DHICA thus was confirmed by demonstrating an identical enzymatic activity for human recombinant MIF (Fig. 5) . As The observation that MIF can act as an enzyme potentially opens a new dimension in our understanding of this mediator, which appears to function physiologically as a counter-regulator of glucocorticoid action within the immune system. In addition to being secreted by the anterior pituitary, MIF is released from immune cells by both pro-inflammatory stimuli and by glucocorticoids (1-4) . Once released, MIF overrides the immunosuppressive effects of glucocorticoids on inflammatory cytokine production and acts to modulate the potent anti-inflammatory properties of glucocorticoids which are necessarily produced as part of the host response to infection and tissue invasion. The finding that MIF, a soluble immunoregulatory mediator, also exhibits an isomerization activity is reminiscent of the protein cyclophilin, which is secreted in response to pro-inflammatory stimuli (25) , but which also functions intracellularly as a peptidyl-prolyl cistrans isomerase and is a target for the powerful immunosuppressant drug cyclosporin (26) .
In conclusion, this study identifies MIF to have tautomerase activity and suggests that elucidation of its true substrate may offer important insight into the mechanism of action of this potent, immunoregulatory protein. These data also provide an approach for the rational design of small molecule, pharmacological inhibitors of MIF that can act in an anti-inflammatory capacity by increasing the therapeutic efficacy of glucocorticoids.
